Tag:
Cerevast Therapeutics
Latest Headlines
Latest Headlines
Cerevast announces initial closing of Series C round
Redmond, WA-based Cerevast Therapeutics has announced the first closing of a $15 million Series C financing, raising roughly $6.6 million, according to an SEC filing. The financing will help support
